Internal Medicine, Sleep Medicine · Spokane, WA
NPI
1376590778
Since 2006
Specialty
Internal Medicine, Sleep Medicine
Code 207RS0012X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
104 West 5th Ave, #400
Spokane, WA, 99204
Phone (509) 353-3960
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
798 services
Medicare patients, 2024
543
Average age 72
Drug cost, 2024
$1.7M
1,440 prescriptions
Company payments, 2025
$99.99
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Donald S Howard was code G0399 (home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation), 178 times for 178 patients. In total Donald S Howard billed 798 services in 13 codes, and Medicare paid $54K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-04.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 178 | 178 | $32.40 | $5,767 |
| 99214 Office E&M - Established | Office | 137 | 129 | $91.03 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 114 | 112 | $12.66 | $1,443 |
| 99204 Office E&M - New | Office | 83 | 83 | $104.79 | $8,697 |
| 99213 Office E&M - Established | Office | 75 | 73 | $66.02 | $4,951 |
| 95811 Sleep Study | Facility | 54 | 53 | $83.79 | $4,525 |
| 99215 Office E&M - Established | Office | 53 | 47 | $130.32 | $6,907 |
| 95810 Sleep Study | Facility | 41 | 41 | $81.19 | $3,329 |
| 99205 Office E&M - New | Office | 21 | 21 | $170.03 | $3,571 |
| 99203 Office E&M - New | Office | 19 | 19 | $62.13 | $1,181 |
By year: 2022 $48K for 590 services; 2023 $53K for 617 services; 2024 $54K for 798 services.
Medicare prescription drug claims, 2024
In 2024, the drug Donald S Howard prescribed most often to Medicare patients was Dextroamphetamine-Amphetamine (Dextroamphetamine/Amphetamine), with 193 prescriptions and refills. In total Donald S Howard wrote 1,440 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 193 | 193 | 31 | $9,390 |
| Gabapentin Generic | 158 | 245 | 37 | $2,933 |
| Modafinil Generic | 92 | 106 | 20 | $6,308 |
| Clonazepam Generic | 71 | 83 | 13 | $845 |
| Dextroamphetamine Sulfate Generic | 68 | 68 | 12 | $8,661 |
| Zolpidem Tartrate Generic | 66 | 78 | 16 | $391 |
| Dextroamphetamine Sulfate Er Dextroamphetamine Sulfate | 55 | 55 | Under 11 | $7,660 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 49 | 79 | 12 | $980 |
| Methylphenidate Hcl Generic | 44 | 44 | 11 | $2,593 |
| Trazodone Hcl Generic | 44 | 54 | 11 | $495 |
| Xywav Sodium,calcium,mag,pot Oxybate | 39 | 39 | Under 11 | $729K |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 38 | 38 | Under 11 | $4,361 |
| Eszopiclone Generic | 36 | 40 | Under 11 | $440 |
| Sodium Oxybate Generic | 34 | 34 | Under 11 | $565K |
| Oxycodone Hcl Generic | 30 | 30 | Under 11 | $591 |
Brand drugs: 174 claims; generic drugs: 1,266 claims; opioid claims: 63.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Donald S Howard $99.99 ($99.99 in general payments such as food, travel and fees) from 1 company. The largest payer was Harmony Biosciences LLC with $99.99.
| Company | Payments | Amount |
|---|---|---|
| Harmony Biosciences LLC HRMY | 1 | $99.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.